BMRN vs NG · P/E 40, rev $1.76B vs $1.96B cap
Biomarin Pharmaceutical Inc (BMRN) versus NovaGold Resources Inc (NG) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
NovaGold Resources Inc (NG) is a gold company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported NG revenue for 2026-05-31 was $0. Net income was -$40.9M. NG currently screens at market cap $1.96B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NG currently screens at market cap $1.96B.
Not investment advice. Open the BMRN and NG stock pages for the full models.
Not investment advice.